Dermal Regeneration Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI3266

Summary Methodology

Dermal Regeneration Market size is expected to grow significantly from 2019 to 2025

Increasing incidence of trauma injuries, burn injuries and chronic diabetic foot ulcers globally will significantly drive dermal regeneration market. Across the globe burns are one of the serious public health problems; majority of these occur in lower-middle-income economies. According to WHO facts published in 2018 an estimated 180,000 deaths occur every year. Additionally, in India more than 1,000,000 individuals are severely or moderately burnt every year and in rural Nepal burns are the second most common injury resulting in five percent of disabilities. Furthermore, as per The National Centre for Biotechnology Information (NCBI) data published in 2017 around 173,000 Bangladeshi children sustain burn injury. Such growing incidents of burn injuries and rising causes of burns provide immense opportunities for dermal regeneration industry growth.

R&D in artificial skin invests in introducing innovative products to the industry thus, boosting business growth. Growing adoption of artificial skin and long-term benefits associated with dermal regeneration should spur industry revenue size. Moreover, few of the major players continuously capitalize in developing safe and innovative products for better lives of patients such factors foster customer preference. However, lack of awareness in under developed economies regarding dermal regeneration may hold back industry growth.

Shark cartilage segment is anticipated to witness robust growth during the forecast period. It is basically used to treat arthritis, wound healing and damage to retina due to diabetes and inflammation of intestine. Increasing incidence of diabetes coupled with technological advancements will favor segmental growth.

Chronic diabetic foot ulcer segment will account for considerable revenue share over the coming years. From the past few years use of cellular dermal matrix has emerged as an alternative treatment option for extremity ulcers. Wide-spread use of dermal matrix should favor segment growth. According to The National Center for Biotechnology Information (NCBI) data published in 2015, foot ulcers are seen in 85% of diabetic patients and are the causes of lower extremity amputation. Additionally, use of dermal matrix in treatment of extremity ulcers should boost segmental growth during the forecast timeline.

Emergency care units will grow significantly due to rise in number of road accidents, wound injuries and burns. Emergency care units offer quick response to any burn injury of the patient thus, augmenting segmental growth.

Asia Pacific dermal regeneration industry is primarily driven by growing adoption of dermal matrix coupled with improving healthcare infrastructure in emerging economies. Moreover, technological advancements in the field of dermal regeneration will further lead to many growth opportunities over the coming years.

Few of the prominent players working in dermal regeneration market include Acell, Advanced BioHealing, La Jolla, CA, Integra LifeScience, Organogenesis, Canton, MA, Smith & Nephew, Platelet BioGenesis, Stratatech and Symatese. Market players working in this industry adopt numerous strategies to compete in the market for longer period of time. For instance, in May 2017, Integra LifeSciences a global medical technology firm launched Integra Dermal Regeneration Template (IDRT) thin single layer in Europe for dermal defects repair and renewal in a single step procedure.

Dermal Regeneration Market By Source, 2014-2025 (USD Million)

  • Cow Collagen
  • Silicone
  • Shark Cartilage

Dermal Regeneration Market By Application, 2014-2025 (USD Million)

  • Burn injuries
  • Chronic diabetic foot ulcer
  • Trauma injuries
  • Others

Dermal Regeneration Market By End-use, 2014-2025 (USD Million)

  • Hospitals
  • Ambulatory surgical centers
  • Emergency care units
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

Company Profiles:

  • Acell
  • Advanced BioHealing, La Jolla, CA
  • Integra LifeScience
  • Organogenesis, Canton, MA
  • Smith & Nephew
  • Platelet BioGenesis
  • Stratatech
  • Symatese

What Information does this report contain?

Historical data coverage: 2016 to 2020; Growth Projections: 2021 to 2027.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X